A. Beale, M. Penney, M. Allison (2005)
The prevalence of iron deficiency among patients presenting with colorectal cancerColorectal Disease, 7
C. Glaser, W. Millesi, G. Kornek, S. Lang, B. Schüll, F. Watzinger, E. Selzer, R. Lavey (2001)
Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx.International journal of radiation oncology, biology, physics, 50 3
M. Auerbach, H. Ballard, J. Trout, M. McIlwain, A. Ackerman, H. Bahrain, S. Balan, L. Barker, J. Rana (2004)
Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22 7
Stone 1 1 Division of Population
Penkae Dangsuwan, T. Manchana (2010)
Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapy.Gynecologic oncology, 116 3
E. Bisbe, J. García-Erce, A. Díez-Lobo, M. Muñoz (2011)
A multicentre comparative study on the efficacy of intravenous ferric carboxymaltose and iron sucrose for correcting preoperative anaemia in patients undergoing major elective surgery.British journal of anaesthesia, 107 3
D. Wyck, M. Martens, Melvin Seid, J. Baker, A. Mangione (2007)
Intravenous Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Postpartum Anemia: A Randomized Controlled TrialObstetrics & Gynecology, 110
M. Hedenus, P. Näsman, J. Liwing (2008)
Economic evaluation in Sweden of epoetin beta with intravenous iron supplementation in anaemic patients with lymphoproliferative malignancies not receiving chemotherapyJournal of Clinical Pharmacy and Therapeutics, 33
Y. Beguin (2002)
Prediction of response and other improvements on the limitations of recombinant human erythropoietin therapy in anemic cancer patients.Haematologica, 87 11
Division of Population, Health Sciences and Education
(2011)
Frequent use of blood transfusions in current treatment practice for chemotherapy-induced anaemia counteracts treatment recommendations aiming for fewer transfusions
P. Pedrazzoli, A. Farris, S. Prete, F. Gaizo, D. Ferrari, C. Bianchessi, G. Colucci, A. Desogus, T. Gamucci, A. Pappalardo, G. Fornarini, P. Pozzi, A. Fabi, R. Labianca, F. Costanzo, S. Secondino, E. Crucitta, F. Apolloni, A. Santo, S. Siena (2008)
Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 10
C. Bokemeyer, M. Aapro, A. Courdi, J. Foubert, H. Link, A. Österborg, L. Repetto, P. Soubeyran (2007)
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.European journal of cancer, 43 2
(2011)
National Comprehensive Cancer Network Inc. NCCN Practice Guidelines in Oncology; Cancer and Chemotherapy-Induced Anemia-v.2
Results: MDTs', doctors' and nurses' predictions were accurate 57.5%, 56.3% and 55.5% of occasions, respectively
Melvin Seid, R. Derman, J. Baker, W. Banach, C. Goldberg, R. Rogers (2008)
Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial.American journal of obstetrics and gynecology, 199 4
(2011)
High prevalence of iron deficiency across different tumors correlates with anemia, increases during cancer treatment and is associated with poor performance status
H. Ludwig, S. Belle, P. Barrett-Lee, G. Birgegard, C. Bokemeyer, P. Gascón, P. Kosmidis, M. Krzakowski, J. Nortier, P. Olmi, M. Schneider, D. Schrijvers (2004)
The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients.European journal of cancer, 40 15
T. Steinmetz, U. Totzke, M. Schweigert, J. Mittermüller, S. Nawka, H. Tesch, M. Groschek, U. Söling, E. Hellebrand, A. Tsamaloukas (2011)
A prospective observational study of anaemia management in cancer patients - results from the German Cancer Anaemia Registry.European journal of cancer care, 20 4
W. Qunibi (2010)
The efficacy and safety of current intravenous iron preparations for the management of iron-deficiency anaemia: a reviewArzneimittelforschung, 60
A. Covic, G. Mircescu (2010)
The safety and efficacy of intravenous ferric carboxymaltose in anaemic patients undergoing haemodialysis: a multi-centre, open-label, clinical studyNephrology Dialysis Transplantation, 25
C. Bokemeyer, M. Aapro, A. Courdi, J. Foubert, H. Link, A. Österborg, L. Repetto, P. Soubeyran (2004)
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer.European journal of cancer, 40 15
A. Khorana, C. Francis, N. Blumberg, E. Culakova, M. Refaai, G. Lyman (2008)
Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer.Archives of internal medicine, 168 21
Annals of Oncology original articles
(2001)
Iron deficiency anaemia -assessment, prevention, and control. A guide for programme managers
Stefanie Kulnigg, S. Stoinov, V. Simanenkov, Larisa Dudar, W. Karnafel, L. Garcia, A. Sambuelli, G. D'Haens, C. Gasche (2008)
A Novel Intravenous Iron Formulation for Treatment of Anemia in Inflammatory Bowel Disease: The Ferric Carboxymaltose (FERINJECT®) Randomized Controlled TrialThe American Journal of Gastroenterology, 103
H. Steinmetz, A. Tsamaloukas, S. Schmitz, J. Wiegand, R. Rohrberg, J. Eggert, F. Breuer, H. Tessen, H. Eustermann, L. Thomas (2011)
A new concept for the differential diagnosis and therapy of anaemia in cancer patientsSupportive Care in Cancer, 19
L. Bastit, A. Vandebroek, S. Altıntaş, B. Gaede, T. Pintér, T. Suto, T. Mossman, Kay Smith, J. Vansteenkiste (2008)
Randomized, multicenter, controlled trial comparing the efficacy and safety of darbepoetin alpha administered every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 10
R. Evstatiev, P. Marteau, T. Iqbal, I. Khalif, J. Stein, B. Bokemeyer, I. Chopey, F. Gutzwiller, L. Riopel, C. Gasche (2011)
FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease.Gastroenterology, 141 3
D. Wyck, A. Mangione, J. Morrison, Phillip Hadley, Judi Jehle, L. Goodnough (2009)
BLOOD MANAGEMENT: Large‐dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trialTransfusion, 49
J. Bohlius, K. Schmidlin, C. Brillant, G. Schwarzer, S. Trelle, J. Seidenfeld, M. Zwahlen, M. Clarke, O. Weingart, S. Kluge, M. Piper, M. Napoli, D. Rades, D. Steensma, B. Djulbegovic, M. Fey, I. Ray-Coquard, V. Moebus, G. Thomas, M. Untch, M. Schumacher, M. Egger, A. Engert (2009)
Erythropoietin or Darbepoetin for patients with cancer--meta-analysis based on individual patient data.The Cochrane database of systematic reviews, 3
F. Verdon, B. Burnand, Claire Stubi, C. Bonard, M. Graff, A. Michaud, T. Bischoff, M. Vevey, J. Studer, L. Herzig, C. Chapuis, J. Tissot, A. Pécoud, Bernard Favrat (2003)
Iron supplementation for unexplained fatigue in non-anaemic women: double blind randomised placebo controlled trialBMJ : British Medical Journal, 326
J. Rizzo, M. Brouwers, P. Hurley, J. Seidenfeld, M. Arcasoy, J. Spivak, Charles Bennett, J. Bohlius, D. Evanchuk, M. Goode, A. Jakubowski, D. Regan, M. Somerfield (2010)
American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer.Blood, 116 20
M. Auerbach, P. Silberstein, R. Webb, S. Averyanova, T. Ciuleanu, James Shao, K. Bridges (2010)
Darbepoetin alfa 300 or 500 μg once every 3 weeks with or without intravenous Iron in patients with chemotherapy‐induced anemiaAmerican Journal of Hematology, 85
S. Anker, J. Colet, G. Filippatos, R. Willenheimer, K. Dickstein, H. Drexler, T. Lüscher, B. Bart, W. Banasiak, J. Niegowska, B. Kirwan, Claudio Mori, Barbara Rothe, S. Pocock, P. Poole‐Wilson, P. Ponikowski (2009)
Ferric carboxymaltose in patients with heart failure and iron deficiency.The New England journal of medicine, 361 25
Wolters Kluwer, I. Cavill, C. Gasche, F. Locatelli, Renal Transplantation, A. Manzoni (2009)
Ferric Carboxymaltose A Review of its Use in Iron-Deficiency Anaemia
Thomas Brownlie, V. Utermohlen, P. Hinton, J. Haas (2004)
Tissue iron deficiency without anemia impairs adaptation in endurance capacity after aerobic training in previously untrained women.The American journal of clinical nutrition, 79 3
(2012)
School of Community-Based Medicine
H. Grotto (2008)
Anaemia of cancer: an overview of mechanisms involved in its pathogenesisMedical Oncology, 25
Gillian Thomas (2001)
The effect of hemoglobin level on radiotherapy outcomes: the Canadian experience.Seminars in oncology, 28 2 Suppl 8
P. Krayenbuehl, E. Battegay, C. Breymann, J. Furrer, G. Schulthess (2011)
Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration.Blood, 118 12
D. Schrijvers (2011)
Management of anemia in cancer patients: transfusions.The oncologist, 16 Suppl 3
D. Henry, N. Dahl, M. Auerbach, S. Tchekmedyian, L. Laufman (2007)
Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy.The oncologist, 12 2
Young Kim, Sang Kim, B. Yoon, H. Cho, E. Nahm, Sung Kim, Jae Kim, J. Kim (2007)
Effect of intravenously administered iron sucrose on the prevention of anemia in the cervical cancer patients treated with concurrent chemoradiotherapy.Gynecologic oncology, 105 1
NCCN Practice Guidelines in Oncology; Cancer and Chemotherapy-Induced Anemia–v.2.2012
Annals of Oncology – Unpaywall
Published: Oct 16, 2012
Access the full text.
Sign up today, get DeepDyve free for 14 days.